Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
DNA, RNA & Cells
Filter     Order     Display # 
Date Item Title
23 Jun 2006 Interim Data On Use Of tgAAC94 In The Treatment Of Inflammatory Arthritis Presented At The European Rheumatology Meeting,
20 Jun 2006 Oncolytics Biotech Inc. Completes Patient Enrolment in Phase Ia Combination REOLYSIN/Radiation Clinical Trial
20 Jun 2006 Lorus Therapeutics announces new clinical program with GTI-2040 in myelodysplastic syndrome and acute myeloid leukemia
13 Jun 2006 IDM Pharma Receives Special Protocol Assessment from FDA for Phase 2/3 Trial of Bexidem for Superficial Bladder Cancer
13 Jun 2006 Isis Pharmaceuticals Reports Positive Phase 2 Data: ISIS 113715 Improves Glucose Control in Patients With Type 2 Diabetes
13 Jun 2006 Multiple Second-Generation Antisense Drugs Show Potential as New Treatments for Metabolic Disorders
12 Jun 2006 Novocell Presents Phase I/II Data on Safety and Response to Encapsulated Islets at the American Diabetes Association's 66th Annual Scientific Session
12 Jun 2006 Targeting MicroRNAs With Antisense Drugs Produces Compelling Preclinical Data in Animal Studies
12 Jun 2006 Sangamo BioSciences Announces 'Late-Breaking' Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
08 Jun 2006 AnGes MG Unveils Future Development Strategies for HGF Gene Medicine
07 Jun 2006 AnGes MG Announces Results of Phase II Clinical Trials of HGF Gene Medicine
06 Jun 2006 SR Pharma plc Announces a Key Technical Breakthrough With its Lyophilized (Dry Powder) Liposomal-Based siRNA Formulation
06 Jun 2006 Amorcyte, Inc. Opens Cell Therapy Trial for Cardiovascular Disease at Emory University; Initial Study to Focus on Safety, Efficacy, and Mechanism of Action
06 Jun 2006 AVI BioPharma Presents Preclinical Results Preventing and Treating Diabetes Using Its ESPRIT Exon Skipping Technology
06 Jun 2006 Cardium Reports Meta-Analysis of Angiogenic Gene Therapy Studies Shows Positive Effects in Men and Women With Heart Disease
06 Jun 2006 Increased Survival and High Response Rates Reported for Introgen's ADVEXIN p53 Therapy
06 Jun 2006 Oncolytics Biotech Inc.’s Research Collaborators Present Positive REOLYSIN® Clinical Trial Data at ASCO Conference
05 Jun 2006 Introgen's INGN 241 in Combination With Tarceva Inhibits Tumor Growth
04 Jun 2006 New Data Support the Safety, Activity and Versatility of Introgen's Oncolytic Virus Program
04 Jun 2006 Eradication of Minimal Residual Disease Reported in Patients with Chronic Lymphocytic Leukemia Treated with Chemotherapy plus Genasense
02 Jun 2006 Introgen's ADVEXIN p53 Therapy Demonstrates Clinical Benefit in Inherited Cancer
02 Jun 2006 H. Lee Moffitt Cancer Center and Inovio Biomedical Announce Positive Results from Pioneering Human Study of Plasmid DNA Delivery Using Electroporation
01 Jun 2006 Isis Pharmaceuticals Receives Orphan Drug Status for ISIS 301012 for the Treatment of Homozygous Familial Hypercholesterolemia
01 Jun 2006 Preliminary Topline Efficacy Results from Phase II Data Show Macugen(R) (pegaptanib sodium injection) Maintained or Improved Vision in over 90 Percent of Patients with Macular Edema Associated with Central Retinal Vein Occlusion (CRVO)
01 Jun 2006 Targeted Genetics Presents Encouraging Interim Data From An Ongoing Phase I/II Trial Of tgAAC94 In Patients With Inflammatory Arthritis
01 Jun 2006 Acuity Pharmaceuticals Reports Positive Initial Phase II Results for Bevasiranib (Cand5) in Wet AMD
01 Jun 2006 Novocell, JDRF Announce Partnership to Clinically Test Encapsulated Human Islets
31 May 2006 MediGene AG Presents Positive Safety Data from the Clinical Phase I/II Trial of Cancer-Killing Virus NV1020
26 May 2006 Data From Sangamo BioSciences' Diabetic Neuropathy Program Published in Diabetes
25 May 2006 Mycobacterial Cell Wall-DNA Complex (MCC) Demonstrates Anticancer Activity in an Animal Model of Colon Cancer
24 May 2006 Long-Term Results from TNFerade(TM) Pancreatic Cancer Study and Updated Survival Results from TNFerade(TM) Esophageal Cancer Study Both Reported at Digestive Disease Week
23 May 2006 Alnylam and Collaborators Present Pre-Clinical Data for RNAi Therapeutics for the Treatment of Respiratory Diseases Including Pandemic Influenza; Results Include Data on Anti-viral Activity of RNAi Therapeutics toward H5N1 Virus
22 May 2006 Cell Genesys Reports Interim Results of CG0070 Phase 1 Trial in Bladder Cancer
18 May 2006 Coley’s ACTILON™ for Chronic Hepatitis C Virus Therapy Granted Fast Track Designation from U.S. Food and Drug Administration
17 May 2006 Neotropix Receives FDA Approval to Begin Clinical Trials With First Investigational Cancer Drug
12 May 2006 Oxford Biomedica Secures Agreement With FDA On Special Protocol Assessment For Phase III Trial Of Trovax In Renal Cancer
12 May 2006 Prosensa and LUMC get approval for in-human trial for ‘smart therapy’ to cure Duchenne Muscular Dystrophy
11 May 2006 AnGes MG Announces Results of Phase I Clinical Trial of HGF Gene Medicine
11 May 2006 AVI BioPharma Presents Initial Results on Hepatitis C Virus Clinical Trial at the International Conference on Antiviral Research Annual Meeting
11 May 2006 AVI BioPharma Presents Initial Results on Hepatitis C Virus Clinical Trial at the International Conference on Antiviral Research Annual Meeting
10 May 2006 Sirna Therapeutics Licenses Worldwide Exclusive Rights to microRNA Technology from University of Massachusetts Medical School
10 May 2006 AVI BioPharma Reports Preclinical Data Against Multiple Strains of Influenza; NEUGENE Antisense Efficacy Against Influenza Strains Reported at the International Conference on Antiviral Research
09 May 2006 Gendux AB and Introgen Therapeutics File European Orphan Drug Designation for ADVEXIN
09 May 2006 Introgen's ADVEXIN p53 Therapy Provided to Cancer Patients With Li-Fraumeni Syndrome
06 May 2006 New Data Highlights Importance of Umbilical Cord Blood for Transplantation
05 May 2006 OSI Pharmaceuticals Summarizes Macugen(R) (pegaptanib sodium injection) Data Presented at Association for Research in Vision and Ophthalmology (ARVO) Meeting
04 May 2006 U.S. FDA Grants Fast Track Designation for Bioniche Bladder Cancer Product
04 May 2006 Sirna Therapeutics Announces Programs in Strategic Research Alliance With GlaxoSmithKline
03 May 2006 Sangamo BioSciences Presents Preclinical Data From ZFP Therapeutic for Age- Related Macular Degeneration
02 May 2006 Oxford Biomedica Reports Encouraging Preclinical Data With Retinostat (R) In Retinopathy And Demonstrates The Potential Of Lentivector (R) In Other Ocular Diseases
 
<< Start < Prev 11 12 13 Next > End >>
Results 501 - 550 of 641

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics